Analgesic nephropathy. Is it caused by multi-analgesic abuse or single substance use?

Drug Safety

Volumn 20, Issue 1, 1999, Pages 15-24

  Elseviers, M M ^a   De Broe, M E ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CAFFEINE; CODEINE; NON PRESCRIPTION DRUG; PARACETAMOL; PHENACETIN;

ANALGESIC NEPHROPATHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG MIXTURE; HUMAN; KIDNEY CALCIFICATION; KIDNEY PAPILLA NECROSIS; KIDNEY SIZE; NEPHROTOXICITY; PRIORITY JOURNAL; REVIEW; SUBSTANCE ABUSE;

EID: 0032918124     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199920010-00003     Document Type: Review

References (48)

1. 1. O. Spühler H.U. Zollinger 1953 Die Chronisch-Interstitiëlle Nephritis Z Klin Med 151 1 50 13137299 Spühler O, Zollinger HU. Die Chronisch-Interstitiëlle Nephritis. Z Klin Med 1953; 151: 1–50
2. 2. K. Larsen C.E. Moller 1959 A renal lesion caused by abuse of phenacetin Acta Med Scand 164 53 71 13660773 10.1111/j.0954-6820.1959.tb00164.x 1:STN:280:DyaG1M%2FptVCnug%3D%3D Larsen K, Moller CE. A renal lesion caused by abuse of phenacetin. Acta Med Scand 1959; 164: 53–71
3. 3. L.A. Jacobs J.G. Morris 1962 Renal papillary necrosis and the abuse of phenacetin Med J Aust 2 14 531 8 Jacobs LA, Morris JG. Renal papillary necrosis and the abuse of phenacetin. Med J Aust 1962; 2(14): 531–8
4. 4. K. Grimlund 1963 Phenacetin and renal damage at a Swedish factory Acta Med Scan 174 Suppl. 405 1 26 Grimlund K. Phenacetin and renal damage at a Swedish factory. Acta Med Scan 1963; 174 Suppl. 405: 1–26
5. 5. United States Renal Data System. 1993 Annual Data Report. The National Institute of Health, The National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney, Urologic and Hematologic Diseases, Bethesda (MD)
6. 6. F.P. Brunner N.H. Selwood 1994 End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality Nephrol Dial Transplant 9 1371 6 7816247 1:STN:280:DyaK2M7hsF2hsg%3D%3D Brunner FP, Selwood NH. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. Nephrol Dial Transplant 1994; 9: 1371–6
7. 7. A.P.S. Disney 1995 Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry Am J Kidney Dis 25 1 165 75 7810521 10.1016/0272-6386(95)90641-X 1:STN:280:DyaK2M7gvFGhtw%3D%3D Disney APS. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry. Am J Kidney Dis 1995; 25(1): 165–75
8. 8. P. Kincaid-Smith 1979 Analgesic nephropathy in Australia Contrib Nephrol 16 57 64 467069 1:STN:280:DyaE1M3jsFGisg%3D%3D Kincaid-Smith P. Analgesic nephropathy in Australia. Contrib Nephrol 1979; 16: 57–64
9. 9. R.S. Nanra 1993 Analgesic nephropathy in the 1990s: an Australian perspective Kidney Int 42 Suppl. 44 86 92 Nanra RS. Analgesic nephropathy in the 1990s: an Australian perspective. Kidney Int 1993; 42 Suppl. 44: 86–92
10. 10. K. Matousovic M.M. Elseviers D. Devecka 1996 Incidence of analgesic nephropathy among patients undergoing renal replacement therapy in Czech republic and Slovak republic Nephrol Dial Transplant 11 1048 51 8671967 10.1093/oxfordjournals.ndt.a027454 1:STN:280:DyaK28zisFarug%3D%3D Matousovic K, Elseviers MM, Devecka D, et al. Incidence of analgesic nephropathy among patients undergoing renal replacement therapy in Czech republic and Slovak republic. Nephrol Dial Transplant 1996; 11: 1048–51
11. 11. J. Matyus L. Ujhelyi I. Karpati 1997 Increase in the incidence of analgesic nephropathy in Hungary [letter] Nephrol Dial Transplant 12 8 1774 9269681 1:STN:280:DyaK2svhsFSgug%3D%3D Matyus J, Ujhelyi L, Karpati I, et al. Increase in the incidence of analgesic nephropathy in Hungary [letter]. Nephrol Dial Transplant 1997; 12(8): 1774
12. 12. T.V. Perneger P.K. Whelton M.J. Klag 1994 Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs N Engl J Med 331 1675 9 7969358 10.1056/NEJM199412223312502 1:STN:280:DyaK2M%2FlvFehtw%3D%3D Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994; 331: 1675–9
13. 13. D.P. Sandler J.C. Smith C.R. Weinberg 1989 Analgesic use and chronic renal disease N Engl J Med 320 1238 43 2651928 10.1056/NEJM198905113201903 1:STN:280:DyaL1M3hvFaiug%3D%3D Sandler DP, Smith JC, Weinberg CR, et al. Analgesic use and chronic renal disease. N Engl J Med 1989; 320: 1238–43
14. 14. W.L. Henrich L.E. Agodoa B. Barrett 1996 Analgesics and the kidney: summary and recommendations to the scientific advisory board of the National Kidney Foundation from ad hoc committee of the National Kidney Foundation Am J Kidney Dis 27 1 162 5 8546133 10.1016/S0272-6386(96)90046-3 1:STN:280:DyaK287jt1ertw%3D%3D Henrich WL, Agodoa LE, Barrett B, et al. Analgesics and the kidney: summary and recommendations to the scientific advisory board of the National Kidney Foundation from ad hoc committee of the National Kidney Foundation. Am J Kidney Dis 1996; 27(1): 162–5
15. 15. A. Rastegar M. Kashgarian 1998 The clinical spectrum of tubulointerstitial nephritis Kidney Int 54 313 27 9690198 10.1046/j.1523-1755.1998.00001.x 1:STN:280:DyaK1czlsVKmtw%3D%3D Rastegar A, Kashgarian M. The clinical spectrum of tubulointerstitial nephritis. Kidney Int 1998; 54: 313–27
16. 16. M.M. Elseviers V. Bosteels P. Cambier 1992 Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure: results of the Belgian study Nephrol Dial Transplant 7 479 86 1320226 1:STN:280:DyaK38zhvFCmsw%3D%3D Elseviers MM, Bosteels V, Cambier P, et al. Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure: results of the Belgian study. Nephrol Dial Transplant 1992; 7: 479–86
17. 17. M.M. Elseviers I. Waller D. Nenov 1995 Evaluation of diagnostic criteria for analgesic nephropathy in patients with endstage renal failure: results of the ANNE study Nephrol Dial Transplant 10 808 14 7566608 1:STN:280:DyaK28%2Fit1OlsQ%3D%3D Elseviers MM, Waller I, Nenov D, et al. Evaluation of diagnostic criteria for analgesic nephropathy in patients with endstage renal failure: results of the ANNE study. Nephrol Dial Transplant 1995; 10: 808–14
18. 18. M.E. Broe De M.M. Elseviers 1998 Analgesic nephropathy N Engl J Med 38 446 52 10.1056/NEJM199802123380707 De Broe ME, Elseviers MM. Analgesic nephropathy. N Engl J Med 1998; 38: 446–52
19. 19. M.M. Elseviers A. Schepper De R. Corthouts 1995 High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure Kidney Int 48 1316 23 8569094 10.1038/ki.1995.416 1:STN:280:DyaK28%2FpvFOltA%3D%3D Elseviers MM, De Schepper A, Corthouts R, et al. High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure. Kidney Int 1995; 48: 1316–23
20. 20. L.F. Prescott 1982 Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics Drugs 23 75 149 7035123 10.2165/00003495-198223010-00004 1:CAS:528:DyaL38XhtlGjt7c%3D Prescott LF. Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs 1982; 23: 75–149
21. 21. R.M. Murray 1978 Genesis of analgesic nephropathy in the United Kingdom Kidney Int 13 50 7 713268 10.1038/ki.1978.7 1:STN:280:DyaE1M%2FltFantw%3D%3D Murray RM. Genesis of analgesic nephropathy in the United Kingdom. Kidney Int 1978; 13: 50–7
22. 22. B.J. Barrett 1996 Acetaminophen and adverse chronic renal outcomes: an appraisal of the epidemiologic evidence Am J Kidney Dis 28 1 14 9 10.1016/S0272-6386(96)90563-6 Barrett BJ. Acetaminophen and adverse chronic renal outcomes: an appraisal of the epidemiologic evidence. Am J Kidney Dis 1996; 28(1) Suppl. 1: 14–9
23. 23. I. Ferguson F. Johnson B. Reay 1977 Aspirin, phenacetin, and the kidney — a rheumatism clinic study Med J Australia 1 950 4 887037 1:STN:280:DyaE2s3jt1aktQ%3D%3D Ferguson I, Johnson F, Reay B, et al. Aspirin, phenacetin, and the kidney — a rheumatism clinic study. Med J Australia 1977; 1: 950–4
24. 24. R.D. Emkey J.A. Mills 1982 Aspirin and analgesic nephropathy JAMA 247 55 7 7053442 10.1001/jama.1982.03320260039027 1:STN:280:DyaL38%2FnvVamtQ%3D%3D Emkey RD, Mills JA. Aspirin and analgesic nephropathy. JAMA 1982; 247: 55–7
25. 25. M. Morlans J.R. Laporte X. Vidal 1990 End-stage renal disease and non-narcotic analgesics: a case control study Br J Clin Pharmacol 30 717 23 2271370 10.1111/j.1365-2125.1990.tb03841.x 1:STN:280:DyaK3M7gsVaqsw%3D%3D Morlans M, Laporte JR, Vidal X, et al. End-stage renal disease and non-narcotic analgesics: a case control study. Br J Clin Pharmacol 1990; 30: 717–23
26. 26. M. Segasothy A.B. Suleimam M. Puvaneswary 1988 Paracetamol: a cause for analgesic nephropathy and end-stage renal disease Nephron 50 50 4 3050572 10.1159/000185116 1:STN:280:DyaL1M%2FhsV2hsQ%3D%3D Segasothy M, Suleimam AB, Puvaneswary M, et al. Paracetamol: a cause for analgesic nephropathy and end-stage renal disease. Nephron 1988; 50: 50–4
27. 27. V.M. Buckalew 1996 Habitual use of acetaminophen as a risk factor for chronic renal failure: a comparison with phenacetin Am J Kidney Dis 28 1 7 13 10.1016/S0272-6386(96)90562-4 Buckalew VM. Habitual use of acetaminophen as a risk factor for chronic renal failure: a comparison with phenacetin. Am J Kidney Dis 1996; 28(1) Suppl. 1: 7–13
28. 28. M.H. Gault B.J. Barret 1998 Analgesic nephropathy Am J Kidney Dis 32 3 351 60 9740150 10.1053/ajkd.1998.v32.pm9740150 1:STN:280:DyaK1cvhtVyltA%3D%3D Gault MH, Barret BJ. Analgesic nephropathy. Am J Kidney Dis 1998; 32(3): 351–60
29. 29. M.E. Broe De M.M. Elseviers U. Bengtsson 1996 Analgesic nephropathy Nephrol Dial Transplant 11 2407 8 9017612 10.1093/oxfordjournals.ndt.a027203 De Broe ME, Elseviers MM, Bengtsson U, et al. Analgesic nephropathy. Nephrol Dial Transplant 1996; 11: 2407–8
30. 30. G.A. Porter 1996 Acetaminophen/aspirin mixtures: experimental data Am J Kidney Dis 28 1 30 3 10.1016/S0272-6386(96)90566-1 Porter GA. Acetaminophen/aspirin mixtures: experimental data. Am J Kidney Dis 1996; 28(1) Suppl. 1: 30–3
31. 31. R.S. Nanra P. Kincaid-Smith 1993 Experimental evidence for nephrotoxicity of analgesics J.H. Stewart Analgesic and NSAID-induced kidney disease Oxford University Press Oxford 17 31 Nanra RS, Kincaid-Smith P. Experimental evidence for nephrotoxicity of analgesics. In: Stewart JH, editor. Analgesic and NSAID-induced kidney disease. Oxford; Oxford University Press, 1993: 17–31
32. 32. G.G. Duggin 1996 Combination analgesic-induced kidney disease: the Australian experience Am J Kidney Dis 28 Suppl. 1 39 47 10.1016/S0272-6386(96)90568-5 Duggin GG. Combination analgesic-induced kidney disease: the Australian experience. Am J Kidney Dis 1996; 28 Suppl. 1: 39–47
33. 33. A. Schwarz 1987 Analgesic-associated nephropathy Klin Wochenschr 65 1 16 3560785 10.1007/BF01785520 1:CAS:528:DyaL2sXhsVyrsro%3D Schwarz A. Analgesic-associated nephropathy. Klin Wochenschr 1987; 65: 1–16
34. 34. J. Raaflaub U.C. Dubach 1969 Dose-dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy Klin Wochenschr 23 1286 7 10.1007/BF01487561 Raaflaub J, Dubach UC. Dose-dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy. Klin Wochenschr 1969; 23: 1286–7
35. 35. L.W. Bluemle M. Goldberg 1968 Renal accumulation of salicylate and phenacetin: possible mechanisms in the nephropathy of analgesic abuse J Clin Invest 47 2507 14 10.1172/JCI105932 1:CAS:528:DyaF1MXislCrsA%3D%3D Bluemle LW, Goldberg M. Renal accumulation of salicylate and phenacetin: possible mechanisms in the nephropathy of analgesic abuse. J Clin Invest 1968; 47: 2507–14
36. 36. A. Schwarz U. Kunzendorf F. Keller 1989 Progression of renal failure in analgesic-associated nephropathy Nephron 53 244 9 2797344 10.1159/000185752 1:STN:280:DyaK3c%2FhsFCksg%3D%3D Schwarz A, Kunzendorf U, Keller F, et al. Progression of renal failure in analgesic-associated nephropathy. Nephron 1989; 53: 244–9
37. 37. R.S. Nanra J. Stuart-Taylor A.H. Leon De 1978 Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlation in Australia Kidney Int 13 79 92 362034 10.1038/ki.1978.11 1:STN:280:DyaE1M%2FltFanuw%3D%3D Nanra RS, Stuart-Taylor J, De Leon AH, et al. Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlation in Australia. Kidney Int 1978; 13: 79–92
38. 38. R.M. Murray 1972 Analgesic nephropathy: removal of phenacetin from proprietary analgesics BMJ 4 131 2 5078444 10.1136/bmj.4.5833.131 1:STN:280:DyaE3s%2Fit1SlsQ%3D%3D Murray RM. Analgesic nephropathy: removal of phenacetin from proprietary analgesics. BMJ 1972; 4: 131–2
39. 39. M.M. Elseviers M.E. Broe De 1987 Wurde das Problem der Analgetika-Nephropathie durch die Entfernung des phenacetins aus analgetischen Mischpräparaten gelöst? Nephrologie 16 187 93 Elseviers MM, De Broe ME. Wurde das Problem der Analgetika-Nephropathie durch die Entfernung des phenacetins aus analgetischen Mischpräparaten gelöst? Nephrologie 1987; 16: 187–93
40. 40. M.M. Elseviers M.E. Broe De 1996 Combination analgesic involvement in the pathogenesis of analgesic nephropathy: the European perspective Am J Kidney Dis 28 Suppl. 1 48 55 10.1016/S0272-6386(96)90569-7 Elseviers MM, De Broe ME. Combination analgesic involvement in the pathogenesis of analgesic nephropathy: the European perspective. Am J Kidney Dis 1996; 28 Suppl. 1: 48–55
41. 41. M. McCredie J.H. Stewart J.F. Mahony 1982 Is phenacetin responsible for analgesic nephropathy in New South Wales? Clin Nephrol 17 3 134 40 7067175 1:STN:280:DyaL387mtlanug%3D%3D McCredie M, Stewart JH, Mahony JF. Is phenacetin responsible for analgesic nephropathy in New South Wales? Clin Nephrol 1982; 17(3): 134–40
42. 42. T.G. Murray P.D. Stolley J.C. Anthony 1983 Epidemiologic study of regular analgesic use and end-stage renal disease Arch Intern Med 143 1687 93 6615090 10.1001/archinte.1983.00350090053009 1:STN:280:DyaL3szgslOiuw%3D%3D Murray TG, Stolley PD, Anthony JC, et al. Epidemiologic study of regular analgesic use and end-stage renal disease. Arch Intern Med 1983; 143: 1687–93
43. 43. W. Pommer E. Bronder E. Greiser 1989 Regular analgesic intake and the risk of end-stage renal failure Am J Nephrol 9 403 12 2801788 10.1159/000168002 1:STN:280:DyaK3c%2FitlKhtg%3D%3D Pommer W, Bronder E, Greiser E, et al. Regular analgesic intake and the risk of end-stage renal failure. Am J Nephrol 1989; 9: 403–12
44. 44. U.C. Dubach B. Rosner E. Pfister 1983 Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968–1979) N Engl J Med 308 357 62 6823240 10.1056/NEJM198302173080703 1:STN:280:DyaL3s7hsFWhsA%3D%3D Dubach UC, Rosner B, Pfister E. Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968–1979). N Engl J Med 1983; 308: 357–62
45. 45. V.M. Buckalew H.M. Schey 1986 Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemiologic evidence Medicine 11 291 303 Buckalew VM, Schey HM. Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemiologic evidence. Medicine 1986; 11: 291–303
46. 46. M.M. Elseviers M.E. Broe De 1995 A long-term prospective controlled study of analgesic abuse in Belgium Kidney Int 48 1912 9 8587252 10.1038/ki.1995.491 1:STN:280:DyaK287mtlamsA%3D%3D Elseviers MM, De Broe ME. A long-term prospective controlled study of analgesic abuse in Belgium. Kidney Int 1995; 48: 1912–9
47. 47. J.K. McLaughlin L. Lipworth W.-H. Chow 1998 Analgesic use and chronic renal failure: a critcal review of the epidemiologic literature Kidney Int 54 679 86 9734593 10.1046/j.1523-1755.1998.00043.x 1:STN:280:DyaK1cvgtlKlsA%3D%3D McLaughlin JK, Lipworth L, Chow W-H, et al. Analgesic use and chronic renal failure: a critcal review of the epidemiologic literature. Kidney Int 1998; 54: 679–86
48. 48. M.M. Elseviers M.E. Broe De 1993 The implication of analgesics in human kidney disease J.H. Stewart Analgesic and NSAID-induced kidney disease Oxford University Press Oxford 32 47 Elseviers MM, De Broe ME. The implication of analgesics in human kidney disease. In: Stewart JH, editor. Analgesic and NSAID-induced kidney disease. Oxford; Oxford University Press, 1993: 32–47